[HTML][HTML] The human Papillomavirus twilight zone–Latency, immune control and subclinical infection

J Doorbar - Tumour Virus Research, 2023 - Elsevier
The incorporation of HPV DNA testing into cervical screening programs has shown that
many HPV-positive women are cytologically normal, with HPV-positivity fluctuating …

[HTML][HTML] Which is the best management for women with normal cervical cytologic findings despite positivity for non-16/18 high risk human papillomaviruses?

M Wu, X Ma, H Li, B Li, C Wang, X Fan, A Fan… - Frontiers in Public …, 2022 - frontiersin.org
Women who test positive for the human papillomavirus (HPV) but have normal cytology
constitute the predominant subgroup of patients in the screening population in the post …

Diagnostic value of high‐risk HPV other than type 16/18 in high‐grade cervical neoplasia among cytology‐negative women: A multicenter retrospective study

A Bai, P Xue, Q Li, Y Jiang, Y Qiao - Cancer Medicine, 2023 - Wiley Online Library
Background Human papillomavirus (HPV) is a necessary cause of cervical cancer, and a
tool more sensitive than cytology for the early screening of cervical precancers. The two …

Use of Virus Genotypes in Machine Learning Diagnostic Prediction Models for Cervical Cancer in Women With High-Risk Human Papillomavirus Infection

T Xiao, C Wang, M Yang, J Yang, X Xu… - JAMA Network …, 2023 - jamanetwork.com
Importance High-risk human papillomavirus (hrHPV) is recognized as an etiologic agent for
cervical cancer, and hrHPV DNA testing is recommended as the preferred method of …

Identification of volatile organic compounds in the urine of patients with cervical cancer. Test concept for timely screening

LD de León-Martínez, R Flores-Ramírez… - Clinica Chimica …, 2021 - Elsevier
The objective of this research was to identify a global chemical pattern of volatile organic
compounds (VOCs) in urine capable of discriminating between women with cervical cancer …

[HTML][HTML] Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China

F Song, P Yan, X Huang, C Wang, X Qu, H Du… - BMC Infectious …, 2021 - Springer
Background Self-sampling for human papillomavirus (HPV) testing is a feasible option to
improve the cervical screening coverage. However, an ideal triage method for HPV-positive …

[HTML][HTML] Clinical analysis of 312 patients with stage IB1-IIA2 cervical squamous cell carcinoma and research on the influencing factors of postoperative recurrence

J Zeng, J Zuo, N Li, HW Yao, YY Zhang, YX Zhao… - BMC Women's …, 2023 - Springer
Objective To investigate the influencing factors of the recurrence of IB1-IIA2 cervical
squamous cell carcinoma after surgical treatment, and to explore the relationship between …

[HTML][HTML] Immediate risk of cervical intraepithelial neoplasia and diagnostic value of colposcopy among cytology-negative women with oncogenic HPV: a retrospective …

W Dai, T Wang, L Chen, Z Qiu, P Chen… - BMC Women's …, 2024 - ncbi.nlm.nih.gov
Background Cervical cancer screening results that are negative for cytology but positive for
high-risk human papillomavirus (HR-HPV) are not uncommon. One-year follow-up is …

[HTML][HTML] Type-specific distribution of cervical hrHPV infection and the association with cytological and histological results in a large population-based cervical Cancer …

F Song, H Du, A Xiao, C Wang, X Huang, Z Liu… - Journal of …, 2020 - ncbi.nlm.nih.gov
Objectives: This study aimed to describe the study design, and to analyze the type-specific
distribution of cervical high-risk human papillomavirus (hrHPV) infection and its association …

[HTML][HTML] Predicting cervical intraepithelial neoplasia and determining the follow-up period in high-risk human papillomavirus patients

L Gong, Y Tang, H Xie, L Zhang, Y Sun - Frontiers in Oncology, 2024 - frontiersin.org
Purpose Despite strong efforts to promote human papillomavirus (HPV) vaccine and cervical
cancer screening, cervical cancer remains a threat to women's reproductive health. Some …